G
Giovambattista Capasso
Researcher at Seconda Università degli Studi di Napoli
Publications - 332
Citations - 6649
Giovambattista Capasso is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Kidney & Renal function. The author has an hindex of 40, co-authored 295 publications receiving 5532 citations. Previous affiliations of Giovambattista Capasso include Albert Einstein College of Medicine & Yale University.
Papers
More filters
Journal ArticleDOI
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Harald Mischak,Guenter Allmaier,Rolf Apweiler,Teresa K. Attwood,Marc Baumann,Ariela Benigni,Samuel E. Bennett,Rainer Bischoff,Erik Bongcam-Rudloff,Giovambattista Capasso,Joshua J. Coon,Patrick C. D'Haese,Anna F. Dominiczak,Mohammed Dakna,Hassan Dihazi,Jochen H. H. Ehrich,Patricia Fernández-Llama,Danilo Fliser,Jørgen Frøkiær,Jérôme Garin,Mark Girolami,William S. Hancock,Marion Haubitz,Denis F. Hochstrasser,Rury R. Holman,John P. A. Ioannidis,Joachim Jankowski,Bruce A. Julian,Jon B. Klein,Walter Kolch,Theo M. Luider,Ziad A. Massy,William B. Mattes,Franck Molina,Bernard Monsarrat,Jan Novak,Karlheinz Peter,Peter Rossing,Marta Sanchez-Carbayo,Joost P. Schanstra,O. John Semmes,Goce Spasovski,Dan Theodorescu,Visith Thongboonkerd,Raymond Vanholder,Timothy D. Veenstra,Eva M. Weissinger,Tadashi Yamamoto,Antonia Vlahou +48 more
TL;DR: It is asserted that successful studies generally use suitable statistical approaches for biomarker definition and confirm results in independent test sets and a brief set of practical and feasible recommendations are described for investigators to properly identify and qualify proteomic biomarkers, which could also be used as reporting requirements.
Journal ArticleDOI
Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy.
Florian Lang,Karin Klingel,Carsten A. Wagner,Carola Stegen,S. Wärntges,Björn Friedrich,M. Lanzendörfer,J. Melzig,Ivano Moschèn,Silvia Steuer,Siegfried Waldegger,Martina Sauter,Markus Paulmichl,Volker Gerke,Teut Risler,Gerardo Gamba,Giovambattista Capasso,Reinhard Kandolf,Steven C. Hebert,Shaul G. Massry,Stefan Bröer +20 more
TL;DR: Excessive extracellular glucose concentrations enhance hSGK transcription, which in turn stimulates renal tubular Na(+) transport, which disclose an additional element in the pathophysiology of diabetic nephropathy.
Journal ArticleDOI
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
Ron T. Gansevoort,Mustafa Arici,Thomas Benzing,Henrik Birn,Giovambattista Capasso,Adrian Covic,Olivier Devuyst,Christiane Drechsler,Kai-Uwe Eckardt,Francesco Emma,Bertrand Knebelmann,Yannick Le Meur,Ziad A. Massy,Albert C.M. Ong,Alberto Ortiz,Franz Schaefer,Roser Torra,Raymond Vanholder,Andrzej Wiecek,Carmine Zoccali,Wim Van Biesen +20 more
TL;DR: This paper aims to provide guidance for making the decision as to which ADPKD patients to treat with tolvaptan, and includes a series of recommendations resulting in a hierarchical decision algorithm that encompasses a sequence of risk-factor assessments in a descending order of reliability.
Journal ArticleDOI
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
Piero Ruggenenti,Barbara Ruggiero,Paolo Cravedi,Marina Vivarelli,Laura Massella,Maddalena Marasa,Antonietta Chianca,Nadia Rubis,Bogdan Ene-Iordache,Michael A. Rudnicki,Rosa Maria Pollastro,Giovambattista Capasso,Antonio Pisani,Marco Pennesi,Francesco Emma,Giuseppe Remuzzi +15 more
TL;DR: Rituximab effectively and safely prevented recurrences and reduced the need for immunosuppression in steroid-dependent or frequently relapsing nephrotic syndrome, and halted disease-associated growth deficit in children.
Journal ArticleDOI
Mechanisms of cognitive dysfunction in CKD.
Davide Viggiano,Carsten A. Wagner,Gianvito Martino,Carmine Zoccali,Robert J. Unwin,Robert J. Unwin,Giovambattista Capasso +6 more
TL;DR: An overview of cognitive dysfunction resulting from CKD, including mild cognitive impairment and dementia, is provided, which seems to be caused by the effects of uraemic neurotoxins and kidney neurotrophins on specific neurons and regions of the brain.